http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160036591-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2a95809b409a67dc931fd4ed02f9740 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1694 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1676 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1694 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5517 |
| filingDate | 2014-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4eea024fe28e83e1d80d84227df5063 |
| publicationDate | 2016-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20160036591-A |
| titleOfInvention | Pharmaceutical formulation containing thienotriazolodiazepine compounds |
| abstract | The present invention also provides a method of treating a patient, comprising administering to a patient a thienotriazololodiazepine compound represented by the following formula (I) or a pharmaceutically acceptable salt or hydrate thereof as a solid dispersion; And a method of treating a lymphocyte leukemia, acute myelogenous leukemia, BCR-ABL positive acute lymphocytic leukemia or CD34 positive acute myelogenous leukemia, comprising administering a pharmaceutically acceptable amount of a composition comprising a pharmaceutically acceptable polymer and a pharmaceutically acceptable polymer will be. In one embodiment, the pharmaceutically acceptable polymer is HPMCAS. ≪ Formula 1 > Wherein R 1 is C 1 -C 4 alkyl, R 2 is C 1 -C 4 alkyl, a is an integer from 1 to 4 , R 3 is C 1 -C 4 alkyl, C 1 -C 4 hydroxyalkyl, C 1 -C 4 alkoxy, phenyl optionally having substituent (s) or heteroaryl optionally having substituent (s). |
| priorityDate | 2013-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 277.